MCC950 | NLRP3 inflammasome inhibitor | InvivoGen
NLRP3‐directed antisense oligonucleotides reduce microglial immunoactivities in vitro - Braatz - Journal of Neurochemistry - Wiley Online Library
NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome - Journal of Allergy and Clinical Immunology
IJMS | Free Full-Text | The NLRP3 Inflammasome: Relevance in Solid Organ Transplantation
Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases | EMBO Molecular Medicine
Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model - eBioMedicine
NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation - ScienceDirect
INFLAMMASOME INHIBITORS - 21st Century Miracle Drugs: Spotlight on Clinical NLRP3 Inflammasome Inhibitors
The NLRP3/NEK7 complex domains and related CAPS mutations. A 3D cartoon... | Download Scientific Diagram
The NLRP3 inflammasome: molecular activation and regulation to therapeutics | Nature Reviews Immunology
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction | Pharmacological Reviews
Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity | Journal of Medicinal Chemistry
The NLRP3 inflammasome: contributions to inflammation-related diseases | Cellular & Molecular Biology Letters | Full Text
The NLRP3 inflammasome: regulation by metabolic signals: Trends in Immunology
Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome | eLife
An update on the regulatory mechanisms of NLRP3 inflammasome activation | Cellular & Molecular Immunology
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells | Science
Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome | eLife
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
CAPS and NLRP3 | SpringerLink
NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium Outflow
Targeting the NLRP3 inflammasome in inflammatory diseases | Nature Reviews Drug Discovery
JCI - Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes
Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases | Science Immunology
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease - ScienceDirect
PKD-mediated NLRP3 activation pathway and the relevant CAPS mutations.... | Download Scientific Diagram
